Literature DB >> 18327975

Enhancement of OX40-induced apoptosis by TNF coactivation in OX40-expressing T cell lines in vitro leading to decreased targets for HIV type 1 production.

Yoshiaki Takahashi1, Reiko Tanaka, Naoki Yamamoto, Yuetsu Tanaka.   

Abstract

OX40, a member of the tumor necrosis factor receptor (TNF-R) superfamily, has been shown to play an important role in the survival of antigen-specific CD4(+) T cells. We have previously reported that stimulation of the OX40-expressing and HIV-1 chronically infected T cell line, ACH-2/OX40, with either OX40 ligand (OX40L)-expressing cells or with TNF resulted in the activation of HIV-1 followed by apoptotic cell death. In the present study we found that costimulation via OX40 and TNF-R in OX40-expressing HIV-1-infected T cell lines leads to a marked reduction of HIV-1 production associated with rapid cell death. Since HIV-1-negative OX40(+) T cell lines underwent rapid apoptotic cell death after OX40L and TNF stimulation, it was reasoned that the ACH-2/OX40 cell death was unlikely to be due to HIV-1 infection. Furthermore, we found that the OX40-mediated apoptosis of the CD4(+) T cell line, Molt-4/CCR5-OX40 (M/R5-OX40), required (1) signals mediated via the cytoplasmic tail of OX40, (2) activation of the caspase cascade, including caspase-8 and caspase-3, and (3) induction of endogenous TNF-alpha, but not of TNF-beta, FasL, or TNF-related apoptosis-inducing ligand (TRAIL), suggesting that this apoptosis occurred indirectly via the TNF/TNF-R system. Finally, a fraction of primary activated CD4(+) T cells, expressing high levels of OX40, underwent apoptosis, as revealed by annexin V staining, after cocultivation with OX40L(+) cells. These results suggest a new biological role of the OX40L/OX40 system in controlling the fate of activated CD4(+) T cells and of controlling HIV-1 infection in inflammatory environments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327975     DOI: 10.1089/aid.2007.0092

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.

Authors:  Kui S Voo; Laura Bover; Megan L Harline; Long T Vien; Valeria Facchinetti; Kazuhiko Arima; Larry W Kwak; Yong J Liu
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

Review 2.  TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?

Authors:  Amit Kumar; Wasim Abbas; Georges Herbein
Journal:  Mediators Inflamm       Date:  2013-12-19       Impact factor: 4.711

3.  Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells.

Authors:  Marie Kunihiro; Hideki Fujii; Takuya Miyagi; Yoshiaki Takahashi; Reiko Tanaka; Takuya Fukushima; Aftab A Ansari; Yuetsu Tanaka
Journal:  Viruses       Date:  2016-07-11       Impact factor: 5.048

4.  Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study.

Authors:  Nasrin Hadi; Seyed Morteza Seifati; Behnaz Nateghi; Parisa Ravaghi; Farinaz Khosravian; Faezeh Namazi; Maryam Fotouhi Firouzabad; Vahid Shaygannejad; Mansoor Salehi
Journal:  Cell J       Date:  2022-07-27       Impact factor: 3.128

5.  OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.

Authors:  Daniel Hirschhorn-Cymerman; Gabrielle A Rizzuto; Taha Merghoub; Adam D Cohen; Francesca Avogadri; Alexander M Lesokhin; Andrew D Weinberg; Jedd D Wolchok; Alan N Houghton
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

6.  Natural OX40L expressed on human T cell leukemia virus type-I-immortalized T cell lines interferes with infection of activated peripheral blood mononuclear cells by CCR5-utilizing human immunodeficiency virus.

Authors:  Daigo Kasahara; Azusa Takara; Yoshiaki Takahashi; Akira Kodama; Reiko Tanaka; Aftab A Ansari; Yuetsu Tanaka
Journal:  Virol J       Date:  2013-11-18       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.